Midodrine hydrochloride| CAS 43218-56-0

Cas No.:	43218-56-0
Chemical Name:	Midodrine hydrochloride
Synonyms:	2-Amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide monohydrochloride;(±)-Midodrine hydrochloride;Midodrine (hydrochloride) NEW;Midodrine Hydrochlor;Midodrine Hydrochloride;(+-)-Midodrin hydrochloride;A 4020 Linz;Abalnate;Alphamine;Metligene;Midamine;Natildine;Shuprase;St. Peter 224;TS 701;Midodrine hydrochloride;Tox21_302723;HMS1568H03;Q-201404;SMR000058833;MGCQZNBCJBRZDT-UHFFFAOYSA-N;SCHEMBL41463;(+/-)-2-AMINO-N-(.BETA.-HYDROXY-2,5-DIMETHOXYPHENETHYL)ACETAMIDE MONOHYDROCHLORIDE;Hipertan;MIDODRINE HYDROCHLORIDE (MART.);rac-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide hydrochloride;NCGC00256810-01;ST-PETER-224;(+/-)-2-AMINO-N-(beta-HYDROXY-2,5-DIMETHOXYPHENETHYL)ACETAMIDE MONOHYDROCHLORIDE;MIDODRINE HYDROCHLORIDE [USP-RS];MIDODRINE HYDROCHLORIDE (USP-RS);CAS-3092-17-9;Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride;ProAmantine;Pharmakon1600-01503257;MIDODRINE HYDROCHLORIDE [MI];Orvaten;AKOS015895724;MFCD00079455;Acetamide, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-,monohydrochloride, (A+/-)-;Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride;Midodrine (hydrochloride);NCGC00178238-05;CS-4689;EINECS 256-148-3;MIDODRINE HYDROCHLORIDE [MART.];NSC758429;2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide hydrochloride;MLS001332567;Monohydrochloride, Midodrine;(+-)-Midodrine hydrochloride;F85240;(+/-)-Midodrine hydrochlorid;NSC 758429;2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride;MIDODRINE HYDROCHLORIDE [ORANGE BOOK];Pro-Amatine (TN);SPECTRUM1503257;Midodrine HCL;CHEBI:31847;SR-05000001847-3;Midodrine hydrochloride [USAN:USP:JAN];Midodrine, Hydrochloride;HS-0099;A-4020 Linz;(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride;Midodrine hydrochloride (USAN:USP:JAN);Midodrine hydrochloride (JAN/USP);NCGC00016620-01;Tox21_110529_1;(+/-)-Midodrin;DTXSID1047493;MIDODRINE HYDROCHLORIDE [JAN];2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride;59JV96YTXV;MIDODRINE HYDROCHLORIDE [WHO-DD];MIDODRINE HYDROCHLORIDE [USP MONOGRAPH];Midodrine hydrochloride, United States Pharmacopeia (USP) Reference Standard;St 1085 [as the base];MIDODRINE HYDROCHLORIDE;43218-56-0;NCGC00095311-01;NS00076195;MIDODRINE HYDROCHLORIDE [VANDF];Acetamide, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-, hydrochloride (1:1);FT-0603627;CCG-39323;NC00573;ST-1085 HYDROCHLORIDE;Metligine;Amatine;Prestwick_625;Pro-Amatine;ACETAMIDE, 2-AMINO-N-(2-(2,5-DIMETHOXYPHENYL)-2-HYDROXYETHYL)-, MONOHYDROCHLORIDE, (+/-)-;s5734;Midodrine Monohydrochloride;3092-17-9;Midodrine hydrochloride [USAN];2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide;hydrochloride;()-Midodrine hydrochlorid;1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride;NSC-758429;Midodrine hydrochloride, analytical standard, for d...
SMILES:	O=C(NCC(C1=CC(OC)=CC=C1OC)O)CN.[H]Cl
Formula:	C₁₂H₁₈N₂O₄^.HCl
M.Wt:	290.74326
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Midodrine is a selective α1-adrenoceptor agonist that acts as a vasopressor/antihypotensive agent for the treatment of dysautonomia and orthostatic hypotension; activates the alpha-adrenergic receptors of the arteriolar and venous vasculature, producing an increase in vascular tone and elevation of blood pressure; does not stimulate cardiac beta-adrenergic receptors, and diffuses poorly across the blood-brain barrier.HypertensionApproved

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.